February 2024 Stock Losers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-02-29, 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of February 2024

100

Ranked drops

-78.02%

Largest, NSTG

96.0%

Below baseline, day +5

1.3%

Median deeper below baseline, day +5

Filter and sort

100 ranked drops in February 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	NSTG Also on the opposite board this month on both boards	-78.02%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology 02/04/2024 19:45 ET after hours	Day +1 -80.41% 2024-02-06 Day +5 -64.05% 2024-02-12 Best recovery within 5 -50.87% 2024-02-09 17.9% of the drop was recovered five sessions later. Month end -74.39% on 2024-02-29
Close before and after $0.4681 to $0.1029 as traded Session open, high, low $0.1850, $0.1872, $0.1000 Opening gap -60.48% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 34,220,258 shares, $3,521,265 Relative volume 44.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
2	ANTX	-74.50%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease 02/12/2024 06:45 ET premarket	Day +1 -80.50% 2024-02-13 Day +5 -81.50% 2024-02-20 Best recovery within 5 -80.50% 2024-02-13 Five sessions later the drop was 9.4% bigger, at -81.50%. Month end -85.10% on 2024-02-29
Close before and after $20.00 to $5.10 split-adjusted Session open, high, low $5.34, $6.10, $4.91 Opening gap -73.30% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 5,700,636 shares, $29,073,244 Relative volume 73.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
3	RAPT	-73.55%	2024-02-20 against the close of 2024-02-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon 02/20/2024 07:30 ET premarket	Day +1 -60.80% 2024-02-21 Day +5 -65.38% 2024-02-27 Best recovery within 5 -60.80% 2024-02-21 11.1% of the drop was recovered five sessions later. Month end -67.00% on 2024-02-29
Close before and after $207.76 to $54.96 as traded Session open, high, low $67.68, $79.52, $54.88 Opening gap -67.42% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 1,747,000 shares, $96,015,120 Relative volume 35.3x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
4	SIEN	-65.13%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process 02/13/2024 08:30 ET premarket	Day +1 -69.21% 2024-02-14 Day +5 -70.26% 2024-02-21 Best recovery within 5 -41.54% 2024-02-15 Five sessions later the drop was 7.9% bigger, at -70.26%. Month end -84.60% on 2024-02-29
Close before and after $0.5850 to $0.2040 as traded Session open, high, low $0.2700, $0.3150, $0.1772 Opening gap -53.85% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 5,022,409 shares, $1,024,571 Relative volume 89.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
5	SQNS	-64.86%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition (terminated)	Renesas Announces Termination of Memorandum of Understanding and Tender Offer for Proposed Acquisition of Sequans 02/22/2024 23:00 ET after hours Sequans at Mobile World Congress 2024 02/23/2024	Day +1 -66.81% 2024-02-26 Day +5 -72.67% 2024-03-01 Best recovery within 5 -66.81% 2024-02-26 Five sessions later the drop was 12.0% bigger, at -72.67%. Month end -73.84% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $64.03 to $22.50 split-adjusted Session open, high, low $31.75, $31.75, $16.58 Opening gap -50.41% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 501,988 shares, $11,294,730 Relative volume 349.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	TENX Also on the opposite board this month on both boards	-64.45%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 02/07/2024 20:01 ET after hours Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering 02/08/2024	Day +1 -65.22% 2024-02-09 Day +5 -70.62% 2024-02-15 Best recovery within 5 -65.22% 2024-02-09 Five sessions later the drop was 9.6% bigger, at -70.62%. Month end -67.81% on 2024-02-29
Close before and after $14.26 to $5.07 split-adjusted Session open, high, low $5.13, $5.60, $4.81 Opening gap -64.03% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 2,683,501 shares, $13,605,350 Relative volume 88.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	CING	-60.42%	2024-02-02 against the close of 2024-02-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Cingulate Announces Pricing of $7.5 Million Public Offering 02/02/2024 09:15 ET premarket	Day +1 -61.01% 2024-02-05 Day +5 -64.29% 2024-02-09 Best recovery within 5 -61.01% 2024-02-05 Five sessions later the drop was 6.4% bigger, at -64.29%. Month end -59.97% on 2024-02-29
Close before and after $40.32 to $15.96 split-adjusted Session open, high, low $24.00, $24.00, $15.36 Opening gap -40.48% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 254,241 shares, $4,057,686 Relative volume 21.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	NERV	-58.82%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia 02/27/2024 08:00 ET premarket	Day +1 -58.38% 2024-02-28 Day +5 -61.76% 2024-03-05 Best recovery within 5 -58.38% 2024-02-28 Five sessions later the drop was 5.0% bigger, at -61.76%. Month end -60.74% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $6.80 to $2.80 split-adjusted Session open, high, low $3.30, $3.40, $2.63 Opening gap -51.47% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 1,946,416 shares, $5,449,965 Relative volume 34.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	POL	-57.41%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Polished.com Provides Corporate Updates 02/13/2024 11:50 ET intraday	Day +1 -59.05% 2024-02-14 Day +5 -62.35% 2024-02-21 Best recovery within 5 -56.17% 2024-02-15 Five sessions later the drop was 8.6% bigger, at -62.35%. Month end -62.51% on 2024-02-29
Close before and after $4.86 to $2.07 as traded Session open, high, low $3.00, $3.25, $1.80 Opening gap -38.27% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 902,519 shares, $1,868,214 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	DMK	-55.79%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	DMK Pharmaceuticals Commences Restructuring Proceeding 02/02/2024 20:28 ET after hours	Day +1 -55.38% 2024-02-06 Day +5 -90.48% 2024-02-12 Best recovery within 5 -55.38% 2024-02-06 Five sessions later the drop was 62.2% bigger, at -90.48%. Month end -83.04% on 2024-02-29
Close before and after $0.5200 to $0.2299 as traded Session open, high, low $0.3602, $0.3980, $0.2126 Opening gap -30.73% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 2,693,213 shares, $619,170 Relative volume 40.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
11	SSRM	-53.70%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	SSR Mining Issues Multi-year Guidance and Technical Reports for All Operating Assets Featuring Production Growth Approaching 800,000 Ounces by 2027 at AISC Trending Towards $1,300 Per Ounce 02/13/2024 06:00 ET premarket SSR Mining Announces Suspension of Operations at Çöpler 02/13/2024	Day +1 -54.01% 2024-02-14 Day +5 -53.60% 2024-02-21 Best recovery within 5 -49.49% 2024-02-16 0.2% of the drop was recovered five sessions later. Month end -55.76% on 2024-02-29
Close before and after $9.72 to $4.50 split-adjusted Session open, high, low $8.25, $8.30, $3.76 Opening gap -15.12% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 67,340,167 shares, $303,030,752 Relative volume 31.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	GTHX Also on the opposite board this month on both boards	-53.13%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee 02/12/2024 16:05 ET after hours	Day +1 -47.43% 2024-02-14 Day +5 -51.79% 2024-02-21 Best recovery within 5 -46.43% 2024-02-15 2.5% of the drop was recovered five sessions later. Month end -25.89% on 2024-02-29
Close before and after $4.48 to $2.10 as traded Session open, high, low $2.49, $2.49, $2.01 Opening gap -44.42% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 9,612,408 shares, $20,186,057 Relative volume 7.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	DPRO	-52.78%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Draganfly Announces Proposed Public Offering of Common Shares & Warrants 02/21/2024 16:05 ET after hours Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering 02/21/2024	Day +1 -56.11% 2024-02-23 Day +5 -42.36% 2024-02-29 Best recovery within 5 -42.36% 2024-02-29 19.7% of the drop was recovered five sessions later. Month end -42.36% on 2024-02-29
Close before and after $9.00 to $4.25 split-adjusted Session open, high, low $5.24, $5.70, $4.16 Opening gap -41.81% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 604,089 shares, $2,567,378 Relative volume 79.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
14	LPSN	-47.08%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LivePerson Announces Fourth Quarter 2023 Financial Results 02/28/2024 16:30 ET after hours	Day +1 -45.83% 2024-03-01 Day +5 -54.37% 2024-03-07 Best recovery within 5 -45.83% 2024-03-01 Five sessions later the drop was 15.5% bigger, at -54.37%. Month end -47.08% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $36.00 to $19.05 split-adjusted Session open, high, low $25.65, $26.25, $18.15 Opening gap -28.75% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 1,242,070 shares, $23,661,434 Relative volume 16.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	GBNH More than one ranked move this month 2+ ranked moves	-46.69%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Greenbrook Announces $1.2 Million Registered Direct Offering 02/22/2024 08:00 ET premarket	Day +1 -68.38% 2024-02-23 Day +5 -87.98% 2024-02-29 Best recovery within 5 -68.38% 2024-02-23 Five sessions later the drop was 88.4% bigger, at -87.98%. Month end -87.98% on 2024-02-29
Close before and after $0.3827 to $0.2040 as traded Session open, high, low $0.2503, $0.2542, $0.1929 Opening gap -34.60% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 8,277,056 shares, $1,688,519 Relative volume 140.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	BKKT More than one ranked move this month 2+ ranked moves	-43.14%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Bakkt Announces $40 Million Registered Direct Offering with Institutional Investors and $10 Million Concurrent Registered Direct Offering 02/29/2024 08:52 ET premarket Bakkt Announces Preliminary 2023 Financial Results; Preliminary Estimates Within Previously Provided Guidance 02/29/2024	Day +1 -43.14% 2024-03-01 Day +5 -41.45% 2024-03-07 Best recovery within 5 -36.15% 2024-03-06 3.9% of the drop was recovered five sessions later. Month end -43.14% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $25.50 to $14.50 split-adjusted Session open, high, low $22.50, $22.50, $14.50 Opening gap -11.76% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 1,552,919 shares, $22,517,326 Relative volume 15.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	RENB	-42.86%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership catalyst from a later release the same session	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine 02/13/2024 09:31 ET intraday Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace 02/13/2024	Day +1 -34.82% 2024-02-14 Day +5 -36.90% 2024-02-21 Best recovery within 5 -32.44% 2024-02-16 13.9% of the drop was recovered five sessions later. Month end -23.21% on 2024-02-29
Close before and after $3.36 to $1.92 as traded Session open, high, low $3.30, $3.35, $1.62 Opening gap -1.79% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 948,980 shares, $1,822,042 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	DAVA	-41.76%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Endava Announces Second Quarter Fiscal Year 2024 Results 02/29/2024 07:12 ET premarket	Day +1 -38.73% 2024-03-01 Day +5 -42.34% 2024-03-07 Best recovery within 5 -38.73% 2024-03-01 Five sessions later the drop was 1.4% bigger, at -42.34%. Month end -41.76% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $63.82 to $37.17 split-adjusted Session open, high, low $46.31, $46.99, $36.37 Opening gap -27.44% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 5,319,184 shares, $197,714,069 Relative volume 29.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	IAS	-41.46%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	IAS Reports Fourth Quarter and Full Year 2023 Financial Results 02/27/2024 16:05 ET after hours	Day +1 -39.42% 2024-02-29 Day +5 -45.67% 2024-03-06 Best recovery within 5 -39.42% 2024-02-29 Five sessions later the drop was 10.2% bigger, at -45.67%. Month end -39.42% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $17.10 to $10.01 as traded Session open, high, low $11.35, $11.78, $9.44 Opening gap -33.63% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 15,754,707 shares, $157,704,617 Relative volume 19.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	CURO	-41.04%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CURO Group Holdings Corp. Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results 02/05/2024 06:01 ET premarket CURO Group Holdings Corp. Announces Consent Solicitation for 7.500% Senior 1.5 Lien Secured Notes Due 2028 02/05/2024	Day +1 -45.19% 2024-02-06 Day +5 -71.91% 2024-02-12 Best recovery within 5 -45.19% 2024-02-06 Five sessions later the drop was 75.2% bigger, at -71.91%. Month end -71.26% on 2024-02-29
Close before and after $0.7654 to $0.4513 as traded Session open, high, low $0.7200, $0.7790, $0.3153 Opening gap -5.93% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 1,078,381 shares, $486,673 Relative volume 30.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
21	GBNH More than one ranked move this month 2+ ranked moves	-40.69%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ 02/23/2024 09:00 ET premarket	Day +1 -76.47% 2024-02-26 Day +5 -77.55% 2024-03-01 Best recovery within 5 -57.40% 2024-02-27 Five sessions later the drop was 90.6% bigger, at -77.55%. Month end -77.45% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $0.2040 to $0.1210 as traded Session open, high, low $0.1800, $0.1800, $0.1031 Opening gap -11.76% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 6,017,722 shares, $728,144 Relative volume 102.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	TOP	-40.63%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	TOP Financial Announces $5 Million Registered Direct Offering 02/12/2024 09:30 ET intraday	Day +1 -48.98% 2024-02-13 Day +5 -47.12% 2024-02-20 Best recovery within 5 -41.37% 2024-02-16 Five sessions later the drop was 16.0% bigger, at -47.12%. Month end -49.72% on 2024-02-29
Close before and after $26.95 to $16.00 split-adjusted Session open, high, low $22.55, $22.55, $15.55 Opening gap -16.33% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 1,297,492 shares, $20,759,872 Relative volume 69.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
23	BKKT More than one ranked move this month 2+ ranked moves	-40.31%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Bakkt Issues Statement Regarding Recently Filed Amendments to Third Quarter Form 10-Q 02/08/2024 15:07 ET intraday	Day +1 -26.90% 2024-02-09 Day +5 -32.41% 2024-02-15 Best recovery within 5 -26.90% 2024-02-09 19.6% of the drop was recovered five sessions later. Month end -60.00% on 2024-02-29
Close before and after $36.25 to $21.64 split-adjusted Session open, high, low $26.00, $26.25, $19.53 Opening gap -28.28% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 1,154,803 shares, $24,987,050 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	EMKR	-39.25%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	EMCORE Reports Fiscal 2024 First Quarter Results 02/08/2024 16:01 ET after hours	Day +1 -38.77% 2024-02-12 Day +5 -30.36% 2024-02-16 Best recovery within 5 -30.36% 2024-02-16 22.6% of the drop was recovered five sessions later. Month end -32.86% on 2024-02-29
Close before and after $6.29 to $3.82 as traded Session open, high, low $4.60, $5.00, $3.80 Opening gap -26.84% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 502,288 shares, $1,918,740 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	IRWD	-37.63%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF) 02/29/2024 06:00 ET premarket	Day +1 -40.05% 2024-03-01 Day +5 -40.94% 2024-03-07 Best recovery within 5 -38.29% 2024-03-04 Five sessions later the drop was 8.8% bigger, at -40.94%. Month end -37.63% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $15.12 to $9.43 split-adjusted Session open, high, low $10.66, $11.00, $8.87 Opening gap -29.50% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 31,529,795 shares, $297,325,967 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	COMM	-37.03%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CommScope Reports Fourth Quarter and Full Year 2023 Results 02/29/2024 07:30 ET premarket	Day +1 -38.65% 2024-03-01 Day +5 -36.76% 2024-03-07 Best recovery within 5 -36.76% 2024-03-07 0.7% of the drop was recovered five sessions later. Month end -37.03% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $1.85 to $1.17 as traded Session open, high, low $1.31, $1.48, $1.16 Opening gap -29.19% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 12,992,083 shares, $15,135,777 Relative volume 7.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	PLCE Also on the opposite board this month on both boards	-36.68%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	The Children's Place Announces Preliminary Unaudited Results for the Fourth Quarter 2023 02/09/2024 06:30 ET premarket	Day +1 -17.01% 2024-02-12 Day +5 +47.44% 2024-02-16 Best recovery within 5 +47.44% 2024-02-16 It recovered the whole drop and closed 47.44% above the pre-news price. Month end -2.58% on 2024-02-29
Close before and after $19.75 to $12.51 split-adjusted Session open, high, low $8.50, $12.52, $8.30 Opening gap -56.96% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 12,098,597 shares, $151,292,955 Relative volume 27.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
28	TRUP	-35.15%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Trupanion Reports Fourth Quarter & Full Year 2023 Results 02/15/2024 16:05 ET after hours	Day +1 -30.87% 2024-02-20 Day +5 -31.60% 2024-02-26 Best recovery within 5 -30.87% 2024-02-20 10.1% of the drop was recovered five sessions later. Month end -24.18% on 2024-02-29
Close before and after $35.28 to $22.88 split-adjusted Session open, high, low $27.02, $29.57, $22.69 Opening gap -23.41% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 4,606,029 shares, $105,385,944 Relative volume 7.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	XMTR	-35.00%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Xometry Reports Fourth Quarter and Full Year 2023 Results 02/29/2024 07:05 ET premarket Xometry Appoints James Miln as New Chief Financial Officer 02/29/2024	Day +1 -40.18% 2024-03-01 Day +5 -40.98% 2024-03-07 Best recovery within 5 -40.18% 2024-03-01 Five sessions later the drop was 17.1% bigger, at -40.98%. Month end -35.00% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $30.09 to $19.56 split-adjusted Session open, high, low $22.47, $23.95, $18.30 Opening gap -25.34% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 4,305,696 shares, $84,219,414 Relative volume 9.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	SNAP	-34.61%	2024-02-07 against the close of 2024-02-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Snap Inc. Announces Fourth Quarter and Full Year 2023 Financial Results 02/06/2024 16:10 ET after hours Snap Inc. Files Annual Report on Form 10-K 02/07/2024	Day +1 -36.39% 2024-02-08 Day +5 -34.67% 2024-02-14 Best recovery within 5 -33.30% 2024-02-12 Five sessions later the drop was 0.2% bigger, at -34.67%. Month end -36.85% on 2024-02-29
Close before and after $17.45 to $11.41 split-adjusted Session open, high, low $12.03, $12.39, $11.08 Opening gap -31.06% Close inside the session range 0.25 of the range, where 1.00 is the high Session volume 185,977,645 shares, $2,122,004,929 Relative volume 9.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	UIS	-33.72%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Unisys Announces 4Q and Full-Year 2023 Results 02/21/2024 07:00 ET premarket	Day +1 -36.03% 2024-02-22 Day +5 -32.31% 2024-02-28 Best recovery within 5 -27.82% 2024-02-27 4.2% of the drop was recovered five sessions later. Month end -33.46% on 2024-02-29
Close before and after $7.80 to $5.17 split-adjusted Session open, high, low $7.71, $7.71, $5.00 Opening gap -1.22% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 3,642,162 shares, $18,829,978 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	NUKK release reads positive	-33.67%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition Release reads positive, stock fell 33.67%	Nukkleus Signs Term Sheet for Acquisition of Leading Cross Border Payments Firm Mercury Global 02/14/2024 07:00 ET premarket	Day +1 -33.67% 2024-02-15 Day +5 -46.94% 2024-02-22 Best recovery within 5 -33.67% 2024-02-15 Five sessions later the drop was 39.4% bigger, at -46.94%. Month end -52.19% on 2024-02-29
Close before and after $15.68 to $10.40 as traded Session open, high, low $13.44, $13.82, $10.00 Opening gap -14.29% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 160,274 shares, $1,666,850 Relative volume 6.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	INGN	-32.66%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results 02/27/2024 16:05 ET after hours	Day +1 -28.80% 2024-02-29 Day +5 -24.73% 2024-03-06 Best recovery within 5 -24.73% 2024-03-06 24.3% of the drop was recovered five sessions later. Month end -28.80% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $9.34 to $6.29 split-adjusted Session open, high, low $7.10, $7.24, $5.82 Opening gap -23.98% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 2,833,189 shares, $17,820,759 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	LTRX	-32.53%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lantronix Reports Record Revenue for Second Quarter of Fiscal 2024 02/08/2024 16:05 ET after hours	Day +1 -31.84% 2024-02-12 Day +5 -26.51% 2024-02-16 Best recovery within 5 -26.51% 2024-02-16 18.5% of the drop was recovered five sessions later. Month end -30.29% on 2024-02-29
Close before and after $5.81 to $3.92 split-adjusted Session open, high, low $4.78, $5.00, $3.86 Opening gap -17.73% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 2,421,700 shares, $9,493,064 Relative volume 15.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	QDEL	-32.20%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results 02/13/2024 16:05 ET after hours	Day +1 -34.13% 2024-02-15 Day +5 -30.28% 2024-02-22 Best recovery within 5 -25.89% 2024-02-21 6.0% of the drop was recovered five sessions later. Month end -31.71% on 2024-02-29
Close before and after $66.77 to $45.27 split-adjusted Session open, high, low $46.27, $48.22, $43.12 Opening gap -30.70% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 10,118,990 shares, $458,086,677 Relative volume 24.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
36	HLF	-31.66%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Herbalife Reports Year-Over-Year Net Sales Growth in Fourth Quarter 2023 02/14/2024 16:24 ET after hours	Day +1 -31.32% 2024-02-16 Day +5 -26.21% 2024-02-23 Best recovery within 5 -26.21% 2024-02-23 17.2% of the drop was recovered five sessions later. Month end -24.85% on 2024-02-29
Close before and after $11.75 to $8.03 split-adjusted Session open, high, low $9.05, $9.15, $6.68 Opening gap -22.98% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 21,484,046 shares, $172,516,889 Relative volume 19.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	CC	-31.51%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results 02/28/2024 22:14 ET after hours	Day +1 -27.65% 2024-03-01 Day +5 -11.70% 2024-03-07 Best recovery within 5 -11.70% 2024-03-07 62.9% of the drop was recovered five sessions later. Month end -31.51% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $28.72 to $19.67 split-adjusted Session open, high, low $18.00, $20.56, $15.10 Opening gap -37.33% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 27,410,197 shares, $539,158,575 Relative volume 29.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	NRXP	-31.24%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock 02/26/2024 16:01 ET after hours NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million 02/27/2024	Day +1 -28.72% 2024-02-28 Day +5 +55.05% 2024-03-05 Best recovery within 5 +55.05% 2024-03-05 It recovered the whole drop and closed 55.05% above the pre-news price. Month end -16.04% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $4.28 to $2.94 split-adjusted Session open, high, low $2.93, $3.08, $2.80 Opening gap -31.50% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 661,053 shares, $1,943,496 Relative volume 13.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	WCC	-31.13%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Wesco International Reports Fourth Quarter and Full Year 2023 Results 02/13/2024 06:00 ET premarket	Day +1 -25.70% 2024-02-14 Day +5 -25.96% 2024-02-21 Best recovery within 5 -23.42% 2024-02-15 16.6% of the drop was recovered five sessions later. Month end -22.35% on 2024-02-29
Close before and after $192.53 to $132.59 split-adjusted Session open, high, low $152.00, $158.55, $132.37 Opening gap -21.05% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 4,869,597 shares, $645,659,866 Relative volume 16.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	HSAI	-31.05%	2024-02-01 against the close of 2024-01-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Hesai Group Statement on the U.S. Department of Defense "Chinese Military Companies" List 01/31/2024 23:32 ET after hours	Day +1 -28.82% 2024-02-02 Day +5 -31.90% 2024-02-08 Best recovery within 5 -26.42% 2024-02-06 Five sessions later the drop was 2.7% bigger, at -31.90%. Month end -36.71% on 2024-02-29
Close before and after $5.83 to $4.02 split-adjusted Session open, high, low $5.08, $5.14, $4.00 Opening gap -12.86% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 4,228,116 shares, $16,997,026 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	FSLY	-30.59%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Fastly Announces Fourth Quarter and Full Year 2023 Financial Results 02/14/2024 16:05 ET after hours	Day +1 -32.88% 2024-02-16 Day +5 -39.63% 2024-02-23 Best recovery within 5 -32.88% 2024-02-16 Five sessions later the drop was 29.6% bigger, at -39.63%. Month end -39.59% on 2024-02-29
Close before and after $23.54 to $16.34 split-adjusted Session open, high, low $18.07, $18.42, $16.26 Opening gap -23.24% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 23,822,607 shares, $389,261,398 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	AAOI	-30.47%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session	Applied Optoelectronics Filed Patent Infringement Lawsuit Against CIG 02/22/2024 16:24 ET after hours Applied Optoelectronics Reports Fourth Quarter and Full Year 2023 Results 02/22/2024 Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan 02/22/2024	Day +1 -27.62% 2024-02-26 Day +5 -24.28% 2024-03-01 Best recovery within 5 -21.47% 2024-02-29 20.3% of the drop was recovered five sessions later. Month end -21.47% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $20.35 to $14.15 split-adjusted Session open, high, low $13.74, $14.68, $12.14 Opening gap -32.48% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 19,663,322 shares, $278,236,006 Relative volume 6.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	EB	-30.29%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Eventbrite Reports Fourth Quarter and Fiscal Year 2023 Financial Results 02/27/2024 16:05 ET after hours	Day +1 -32.69% 2024-02-29 Day +5 -36.66% 2024-03-06 Best recovery within 5 -31.61% 2024-03-01 Five sessions later the drop was 21.0% bigger, at -36.66%. Month end -32.69% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $8.32 to $5.80 as traded Session open, high, low $6.17, $6.17, $5.52 Opening gap -25.84% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 9,889,726 shares, $57,360,411 Relative volume 10.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	ADVM Also on the opposite board this month on both boards	-29.89%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD 02/08/2024 07:00 ET premarket	Day +1 -38.43% 2024-02-09 Day +5 -28.83% 2024-02-15 Best recovery within 5 -18.51% 2024-02-13 3.5% of the drop was recovered five sessions later. Month end -29.54% on 2024-02-29
Close before and after $28.10 to $19.70 as traded Session open, high, low $29.50, $29.70, $19.60 Opening gap +4.98% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 1,518,409 shares, $29,912,657 Relative volume 29.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	CNVS Also on the opposite board this month on both boards	-29.79%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Cineverse Reports Third Quarter Fiscal Year 2024 Results 02/14/2024 16:05 ET after hours CINEVERSE ANNOUNCES THE LAUNCH OF NEW AD PLATFORM 'CINEVERSE 360' 02/15/2024	Day +1 -34.47% 2024-02-16 Day +5 -40.00% 2024-02-23 Best recovery within 5 -34.47% 2024-02-16 Five sessions later the drop was 34.3% bigger, at -40.00%. Month end -43.83% on 2024-02-29
Close before and after $2.35 to $1.65 split-adjusted Session open, high, low $1.70, $1.94, $1.57 Opening gap -27.66% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 1,642,757 shares, $2,710,549 Relative volume 27.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	UPXI	-29.71%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Upexi Reports Fiscal Second Quarter 2024 Financial Results 02/14/2024 16:05 ET after hours	Day +1 -41.30% 2024-02-16 Day +5 -52.89% 2024-02-23 Best recovery within 5 -38.62% 2024-02-20 Five sessions later the drop was 78.0% bigger, at -52.89%. Month end -62.75% on 2024-02-29
Close before and after $27.60 to $19.40 split-adjusted Session open, high, low $21.20, $22.18, $16.00 Opening gap -23.19% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 34,686 shares, $672,908 Relative volume 9.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	AGEN	-29.54%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design 02/15/2024 07:02 ET premarket	Day +1 -29.40% 2024-02-16 Day +5 -26.49% 2024-02-23 Best recovery within 5 -26.49% 2024-02-23 10.3% of the drop was recovered five sessions later. Month end -27.79% on 2024-02-29
Close before and after $18.56 to $13.08 split-adjusted Session open, high, low $17.20, $17.20, $11.42 Opening gap -7.32% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 2,226,092 shares, $29,108,379 Relative volume 4.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	TWKS	-28.85%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Thoughtworks Reports Fourth Quarter and Full Year 2023 Financial Results 02/27/2024 07:17 ET premarket	Day +1 -30.80% 2024-02-28 Day +5 -43.82% 2024-03-05 Best recovery within 5 -30.80% 2024-02-28 Five sessions later the drop was 51.9% bigger, at -43.82%. Month end -32.32% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $4.61 to $3.28 as traded Session open, high, low $3.20, $3.39, $2.90 Opening gap -30.59% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 4,873,875 shares, $15,986,310 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	BELFB Same release as rank 90	-28.65%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Bel Reports Fourth Quarter and Full Year 2023 Results 02/21/2024 17:20 ET after hours	Day +1 -28.33% 2024-02-23 Day +5 -25.87% 2024-02-29 Best recovery within 5 -24.76% 2024-02-26 9.7% of the drop was recovered five sessions later. Month end -25.87% on 2024-02-29
Close before and after $70.11 to $50.02 split-adjusted Session open, high, low $52.67, $53.83, $45.75 Opening gap -24.88% Close inside the session range 0.53 of the range, where 1.00 is the high Session volume 1,190,545 shares, $59,551,061 Relative volume 13.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	PANW	-28.44%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Palo Alto Networks Reports Fiscal Second Quarter 2024 Financial Results 02/20/2024 16:05 ET after hours Palo Alto Networks Enables Customers to Break Free from Legacy Solutions with Cortex Platform Offer for Endpoint Security 02/21/2024	Day +1 -26.84% 2024-02-22 Day +5 -13.64% 2024-02-28 Best recovery within 5 -13.64% 2024-02-28 52.0% of the drop was recovered five sessions later. Month end -15.17% on 2024-02-29
Close before and after $183.05 to $130.99 split-adjusted Session open, high, low $137.60, $137.99, $130.05 Opening gap -24.83% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 87,869,818 shares, $11,509,628,111 Relative volume 15.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	CYH	-28.22%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Community Health Systems, Inc. Announces Fourth Quarter and Year Ended December 31, 2023 Results 02/20/2024 16:15 ET after hours	Day +1 -34.65% 2024-02-22 Day +5 -32.18% 2024-02-28 Best recovery within 5 -27.48% 2024-02-23 Five sessions later the drop was 14.0% bigger, at -32.18%. Month end -30.94% on 2024-02-29
Close before and after $4.04 to $2.90 split-adjusted Session open, high, low $3.33, $3.40, $2.79 Opening gap -17.57% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 9,394,418 shares, $27,243,812 Relative volume 6.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	QMCO	-28.15%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Quantum Announces Delayed Form 10-Q Filing for Quarter Ending December 31, 2023 02/14/2024 16:10 ET after hours	Day +1 -26.70% 2024-02-16 Day +5 -37.33% 2024-02-23 Best recovery within 5 -26.70% 2024-02-16 Five sessions later the drop was 32.6% bigger, at -37.33%. Month end -29.22% on 2024-02-29
Close before and after $13.64 to $9.80 split-adjusted Session open, high, low $14.40, $14.40, $9.31 Opening gap +5.56% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 121,499 shares, $1,190,933 Relative volume 13.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	LMND	-27.72%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lemonade Announces Fourth Quarter and Full Year 2023 Financial Results 02/27/2024 16:30 ET after hours	Day +1 -25.23% 2024-02-29 Day +5 -25.92% 2024-03-06 Best recovery within 5 -20.58% 2024-03-04 6.5% of the drop was recovered five sessions later. Month end -25.23% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $21.72 to $15.70 split-adjusted Session open, high, low $16.56, $17.40, $15.50 Opening gap -23.76% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 13,123,424 shares, $206,037,757 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	ELTK	-26.95%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Eltek Announces Pricing of Public Offering of Ordinary Shares. 02/12/2024 18:37 ET after hours	Day +1 -27.44% 2024-02-14 Day +5 -40.84% 2024-02-21 Best recovery within 5 -27.44% 2024-02-14 Five sessions later the drop was 51.5% bigger, at -40.84%. Month end -37.58% on 2024-02-29
Close before and after $22.40 to $16.36 split-adjusted Session open, high, low $19.05, $20.00, $16.34 Opening gap -14.94% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 577,453 shares, $9,447,131 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	FOXF	-26.82%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Fox Factory Holding Corp. Reports Fourth Quarter and Fiscal 2023 Financial Results 02/22/2024 16:05 ET after hours	Day +1 -24.92% 2024-02-26 Day +5 -18.64% 2024-03-01 Best recovery within 5 -18.64% 2024-03-01 30.5% of the drop was recovered five sessions later. Month end -22.15% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $64.98 to $47.55 split-adjusted Session open, high, low $46.71, $49.12, $44.10 Opening gap -28.12% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 3,001,876 shares, $142,739,204 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	NVAX	-26.74%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights 02/28/2024 08:00 ET premarket	Day +1 -17.94% 2024-02-29 Day +5 -6.81% 2024-03-06 Best recovery within 5 -6.81% 2024-03-06 74.5% of the drop was recovered five sessions later. Month end -17.94% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $6.02 to $4.41 split-adjusted Session open, high, low $4.64, $4.70, $4.23 Opening gap -22.92% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 32,269,323 shares, $142,307,714 Relative volume 4.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	NOVA	-26.69%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sunnova Reports Fourth Quarter and Full Year 2023 Financial Results 02/21/2024 16:05 ET after hours	Day +1 -36.36% 2024-02-23 Day +5 -37.72% 2024-02-29 Best recovery within 5 -36.36% 2024-02-23 Five sessions later the drop was 41.3% bigger, at -37.72%. Month end -37.72% on 2024-02-29
Close before and after $11.69 to $8.57 as traded Session open, high, low $11.38, $11.57, $8.50 Opening gap -2.65% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 22,328,677 shares, $191,356,762 Relative volume 3.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
58	BETS	-26.67%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Bit Brother Limited Receives Notice of Delisting from Nasdaq 02/02/2024 16:05 ET after hours	Day +1 -35.00% 2024-02-06 Day +5 +5.00% 2024-02-12 Best recovery within 5 +16.67% 2024-02-08 It recovered the whole drop and closed 5.00% above the pre-news price. Month end +15.00% on 2024-02-29
Close before and after $3.00 to $2.20 as traded Session open, high, low $2.05, $2.27, $1.73 Opening gap -31.67% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 1,535,735 shares, $3,378,617 Relative volume 1.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
59	CPS	-26.25%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Improved Cash Flow Highlights Cooper Standard's Fourth Quarter and Full Year 2023 Results 02/15/2024 16:30 ET after hours	Day +1 -24.27% 2024-02-20 Day +5 -25.57% 2024-02-26 Best recovery within 5 -24.27% 2024-02-20 2.6% of the drop was recovered five sessions later. Month end -26.77% on 2024-02-29
Close before and after $19.20 to $14.16 split-adjusted Session open, high, low $16.79, $16.90, $13.79 Opening gap -12.55% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 1,207,322 shares, $17,095,680 Relative volume 8.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	SMMT	-26.23%	2024-02-20 against the close of 2024-02-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023 02/20/2024 07:00 ET premarket	Day +1 -18.93% 2024-02-21 Day +5 -13.21% 2024-02-27 Best recovery within 5 -8.48% 2024-02-23 49.6% of the drop was recovered five sessions later. Month end -10.45% on 2024-02-29
Close before and after $5.07 to $3.74 split-adjusted Session open, high, low $4.87, $4.91, $3.42 Opening gap -3.94% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 6,322,035 shares, $23,644,411 Relative volume 3.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
61	CRGE	-25.96%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Charge Enterprises Announces Decision of Nasdaq Hearings Panel To Delist Common Shares 02/22/2024 16:15 ET after hours	Day +1 -19.51% 2024-02-26 Day +5 -73.21% 2024-03-01 Best recovery within 5 -17.58% 2024-02-27 Five sessions later the drop was 182.0% bigger, at -73.21%. Month end -79.81% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $0.0728 to $0.0539 as traded Session open, high, low $0.0400, $0.0827, $0.0351 Opening gap -45.05% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 66,675,989 shares, $3,593,836 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	CSTL	-25.95%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results 02/28/2024 16:05 ET after hours	Day +1 -18.25% 2024-03-01 Day +5 -14.92% 2024-03-07 Best recovery within 5 -8.53% 2024-03-05 42.5% of the drop was recovered five sessions later. Month end -25.95% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $24.39 to $18.06 split-adjusted Session open, high, low $24.85, $24.87, $17.42 Opening gap +1.89% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 965,206 shares, $17,431,620 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	RIVN	-25.60%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Rivian Releases Fourth Quarter and Full Year 2023 Financial Results 02/21/2024 16:10 ET after hours	Day +1 -34.57% 2024-02-23 Day +5 -26.45% 2024-02-29 Best recovery within 5 -26.45% 2024-02-29 Five sessions later the drop was 3.3% bigger, at -26.45%. Month end -26.45% on 2024-02-29
Close before and after $15.39 to $11.45 split-adjusted Session open, high, low $11.98, $12.25, $11.06 Opening gap -22.16% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 191,810,436 shares, $2,196,229,492 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	ENCP	-25.43%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	Energem Corp. Announces Shareholder Approval of Business Combination with Graphjet Technology Sdn. Bhd. 02/28/2024 15:55 ET intraday	Day +1 -23.25% 2024-02-29 Day +5 -24.61% 2024-03-06 Best recovery within 5 -23.25% 2024-02-29 3.2% of the drop was recovered five sessions later. Month end -23.25% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $11.01 to $8.21 as traded Session open, high, low $11.11, $11.92, $8.21 Opening gap +0.91% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 9,702 shares, $79,653 Relative volume 1.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	PHXM	-25.32%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market 02/20/2024 16:05 ET after hours	Day +1 -25.32% 2024-02-22 Day +5 -27.70% 2024-02-28 Best recovery within 5 -21.12% 2024-02-26 Five sessions later the drop was 9.4% bigger, at -27.70%. Month-end is not shown: no closing price is available for 2024-02-29.
Close before and after $3.79 to $2.83 as traded Session open, high, low $3.31, $3.31, $2.70 Opening gap -12.66% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 12,295 shares, $34,795 Relative volume 17.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	STGW	-25.00%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	STAGWELL INC. (NASDAQ: STGW) REPORTS RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2023 02/27/2024 07:00 ET premarket	Day +1 -25.93% 2024-02-28 Day +5 -25.36% 2024-03-05 Best recovery within 5 -19.94% 2024-03-04 Five sessions later the drop was 1.4% bigger, at -25.36%. Month end -23.93% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $7.02 to $5.27 split-adjusted Session open, high, low $5.22, $6.15, $5.13 Opening gap -25.64% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 2,075,622 shares, $10,928,150 Relative volume 5.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	AUPH	-24.47%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value 02/15/2024 06:00 ET premarket	Day +1 -26.60% 2024-02-16 Day +5 -25.35% 2024-02-23 Best recovery within 5 -24.72% 2024-02-22 Five sessions later the drop was 3.6% bigger, at -25.35%. Month end -28.23% on 2024-02-29
Close before and after $7.97 to $6.02 split-adjusted Session open, high, low $6.00, $6.20, $5.50 Opening gap -24.72% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 19,625,716 shares, $118,146,810 Relative volume 12.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	APPS	-24.40%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Digital Turbine Reports Fiscal 2024 Third Quarter Financial Results 02/07/2024 16:05 ET after hours	Day +1 -22.42% 2024-02-09 Day +5 -29.96% 2024-02-15 Best recovery within 5 -22.42% 2024-02-09 Five sessions later the drop was 22.8% bigger, at -29.96%. Month end -37.10% on 2024-02-29
Close before and after $5.04 to $3.81 split-adjusted Session open, high, low $4.22, $4.30, $3.70 Opening gap -16.27% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 10,835,357 shares, $41,282,710 Relative volume 8.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	LSPD	-24.37%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lightspeed Announces Third Quarter 2024 Financial Results 02/08/2024 06:50 ET premarket	Day +1 -28.10% 2024-02-09 Day +5 -25.24% 2024-02-15 Best recovery within 5 -25.24% 2024-02-15 Five sessions later the drop was 3.6% bigger, at -25.24%. Month end -28.26% on 2024-02-29
Close before and after $19.57 to $14.80 split-adjusted Session open, high, low $17.15, $17.65, $14.55 Opening gap -12.37% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 9,051,929 shares, $133,968,549 Relative volume 11.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	PTON	-24.28%	2024-02-01 against the close of 2024-01-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Peloton Interactive, Inc. Reports Second Quarter Fiscal 2024 Financial Results 02/01/2024 07:00 ET premarket	Day +1 -23.74% 2024-02-02 Day +5 -18.53% 2024-02-08 Best recovery within 5 -18.53% 2024-02-08 23.7% of the drop was recovered five sessions later. Month end -18.71% on 2024-02-29
Close before and after $5.56 to $4.21 split-adjusted Session open, high, low $5.23, $5.30, $4.17 Opening gap -5.94% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 84,237,884 shares, $354,641,492 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	EGAN	-24.25%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	eGain Reports Growing Profitability in its Fiscal Second Quarter; New Logos Increase with AssistGPT AI Offering 02/08/2024 16:05 ET after hours	Day +1 -22.15% 2024-02-12 Day +5 -22.02% 2024-02-16 Best recovery within 5 -21.36% 2024-02-14 9.2% of the drop was recovered five sessions later. Month end -19.66% on 2024-02-29
Close before and after $7.63 to $5.78 split-adjusted Session open, high, low $6.74, $6.74, $5.61 Opening gap -11.66% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 407,762 shares, $2,356,864 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	TDS	-23.86%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	TDS reports fourth quarter and full year 2023 results 02/16/2024 07:30 ET premarket TDS announces first quarter 2024 dividends 02/16/2024	Day +1 -21.96% 2024-02-20 Day +5 -21.10% 2024-02-26 Best recovery within 5 -20.55% 2024-02-21 11.6% of the drop was recovered five sessions later. Month end -17.03% on 2024-02-29
Close before and after $18.44 to $14.04 split-adjusted Session open, high, low $17.05, $17.36, $13.81 Opening gap -7.54% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 4,967,431 shares, $69,742,731 Relative volume 5.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	VICR	-23.85%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2023 02/22/2024 16:05 ET after hours	Day +1 -18.23% 2024-02-26 Day +5 -19.53% 2024-03-01 Best recovery within 5 -18.23% 2024-02-26 18.1% of the drop was recovered five sessions later. Month end -20.50% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $46.84 to $35.67 split-adjusted Session open, high, low $37.76, $40.38, $35.28 Opening gap -19.39% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 1,517,534 shares, $54,130,438 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	ROKU	-23.81%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session	Roku Hits Major Milestones, Surpassing 80 Million Active Accounts and More than 100 Billion Streaming Hours in 2023 02/15/2024 16:05 ET after hours Roku Releases Fourth Quarter and Fiscal Year 2023 Financial Results 02/15/2024	Day +1 -28.84% 2024-02-20 Day +5 -31.90% 2024-02-26 Best recovery within 5 -28.84% 2024-02-20 Five sessions later the drop was 34.0% bigger, at -31.90%. Month end -33.14% on 2024-02-29
Close before and after $94.50 to $72.00 split-adjusted Session open, high, low $76.97, $78.61, $71.00 Opening gap -18.55% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 40,211,806 shares, $2,895,250,032 Relative volume 8.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	TDOC	-23.67%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Teladoc Health Reports Fourth Quarter and Full Year 2023 Results 02/20/2024 16:05 ET after hours	Day +1 -25.77% 2024-02-22 Day +5 -26.35% 2024-02-28 Best recovery within 5 -25.77% 2024-02-22 Five sessions later the drop was 11.3% bigger, at -26.35%. Month end -26.40% on 2024-02-29
Close before and after $20.49 to $15.64 split-adjusted Session open, high, low $16.75, $16.82, $15.16 Opening gap -18.25% Close inside the session range 0.29 of the range, where 1.00 is the high Session volume 29,938,549 shares, $468,238,906 Relative volume 10.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	SYM	-23.57%	2024-02-06 against the close of 2024-02-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Symbotic Reports First Quarter Fiscal Year 2024 Results 02/05/2024 16:01 ET after hours	Day +1 -20.81% 2024-02-07 Day +5 -11.85% 2024-02-13 Best recovery within 5 -5.83% 2024-02-09 49.7% of the drop was recovered five sessions later. Month end -20.56% on 2024-02-29
Close before and after $49.60 to $37.91 split-adjusted Session open, high, low $41.26, $41.91, $37.28 Opening gap -16.81% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 8,008,227 shares, $303,591,886 Relative volume 7.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	DDD	-23.14%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited) 02/27/2024 18:15 ET after hours	Day +1 -20.84% 2024-02-29 Day +5 -13.58% 2024-03-06 Best recovery within 5 -13.58% 2024-03-06 41.3% of the drop was recovered five sessions later. Month end -20.84% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $5.23 to $4.02 split-adjusted Session open, high, low $4.27, $4.28, $3.80 Opening gap -18.36% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 8,635,473 shares, $34,714,601 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	DBX	-22.93%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Dropbox Announces Fourth Quarter and Fiscal 2023 Results 02/15/2024 16:04 ET after hours	Day +1 -25.54% 2024-02-20 Day +5 -27.78% 2024-02-26 Best recovery within 5 -25.54% 2024-02-20 Five sessions later the drop was 21.2% bigger, at -27.78%. Month end -26.40% on 2024-02-29
Close before and after $32.54 to $25.08 split-adjusted Session open, high, low $27.98, $27.98, $24.63 Opening gap -14.01% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 21,087,571 shares, $528,876,281 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	CAR	-22.90%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Avis Budget Group Reports Fourth Quarter and Full Year Results 02/12/2024 16:02 ET after hours	Day +1 -28.78% 2024-02-14 Day +5 -39.93% 2024-02-21 Best recovery within 5 -28.08% 2024-02-15 Five sessions later the drop was 74.4% bigger, at -39.93%. Month end -35.83% on 2024-02-29
Close before and after $168.36 to $129.81 split-adjusted Session open, high, low $160.77, $161.00, $128.42 Opening gap -4.51% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 4,304,243 shares, $558,733,784 Relative volume 8.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	GTN	-22.77%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Gray Finishes 2023 In A Strong Position and Issues Positive Outlook for 2024 02/23/2024 06:45 ET premarket	Day +1 -24.91% 2024-02-26 Day +5 -28.05% 2024-03-01 Best recovery within 5 -24.91% 2024-02-26 Five sessions later the drop was 23.2% bigger, at -28.05%. Month end -26.54% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $7.95 to $6.14 split-adjusted Session open, high, low $7.28, $7.40, $5.97 Opening gap -8.43% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 4,410,400 shares, $27,079,856 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	SABR	-22.45%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sabre's fourth quarter and full year 2023 earnings materials available on its Investor Relations website 02/15/2024 07:55 ET premarket	Day +1 -32.88% 2024-02-16 Day +5 -38.10% 2024-02-23 Best recovery within 5 -32.88% 2024-02-16 Five sessions later the drop was 69.7% bigger, at -38.10%. Month end -39.91% on 2024-02-29
Close before and after $4.41 to $3.42 split-adjusted Session open, high, low $3.61, $3.67, $3.12 Opening gap -18.14% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 28,414,910 shares, $97,178,992 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	LITE	-22.43%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lumentum Announces Fiscal Second Quarter 2024 Financial Results 02/08/2024 07:30 ET premarket	Day +1 -14.57% 2024-02-09 Day +5 -16.30% 2024-02-15 Best recovery within 5 -14.34% 2024-02-12 27.3% of the drop was recovered five sessions later. Month end -17.53% on 2024-02-29
Close before and after $58.77 to $45.59 split-adjusted Session open, high, low $51.26, $51.32, $45.38 Opening gap -12.78% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 11,262,470 shares, $513,399,695 Relative volume 11.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	UDMY	-22.34%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Udemy Reports Fourth Quarter and Full Year 2023 Results 02/14/2024 16:06 ET after hours Udemy Announces Share Repurchase Program 02/14/2024	Day +1 -21.09% 2024-02-16 Day +5 -24.13% 2024-02-23 Best recovery within 5 -21.09% 2024-02-16 Five sessions later the drop was 8.0% bigger, at -24.13%. Month end -19.34% on 2024-02-29
Close before and after $14.01 to $10.88 as traded Session open, high, low $11.91, $12.07, $10.71 Opening gap -14.99% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 7,257,643 shares, $78,963,156 Relative volume 12.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	JG	-21.92%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Aurora Mobile’s JPush SDK Passes CAICT’s SDK Security Test and Evaluation 02/21/2024 04:00 ET premarket	Day +1 -14.57% 2024-02-22 Day +5 -6.57% 2024-02-28 Best recovery within 5 -4.77% 2024-02-26 70.0% of the drop was recovered five sessions later. Month end -3.69% on 2024-02-29
Close before and after $3.13 to $2.44 split-adjusted Session open, high, low $3.10, $3.10, $2.36 Opening gap -0.81% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 24,562 shares, $59,931 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	SWIN	-21.76%	2024-02-01 against the close of 2024-01-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	SOLOWIN HOLDINGS Debuts in Investor Conferences in San Juan and Atlantic City 02/01/2024 09:00 ET premarket	Day +1 -19.80% 2024-02-02 Day +5 +3.73% 2024-02-08 Best recovery within 5 +3.73% 2024-02-08 It recovered the whole drop and closed 3.73% above the pre-news price. Month end +114.31% on 2024-02-29
Close before and after $5.10 to $3.99 as traded Session open, high, low $4.86, $4.95, $3.26 Opening gap -4.71% Close inside the session range 0.43 of the range, where 1.00 is the high Session volume 286,053 shares, $1,141,351 Relative volume 3.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	TDC	-21.66%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Teradata Reports Fourth Quarter and Full-Year 2023 Financial Results 02/12/2024 16:05 ET after hours	Day +1 -20.43% 2024-02-14 Day +5 -22.75% 2024-02-21 Best recovery within 5 -20.43% 2024-02-14 Five sessions later the drop was 5.0% bigger, at -22.75%. Month end -22.89% on 2024-02-29
Close before and after $48.79 to $38.22 split-adjusted Session open, high, low $38.99, $39.12, $36.72 Opening gap -20.09% Close inside the session range 0.63 of the range, where 1.00 is the high Session volume 7,190,652 shares, $274,826,719 Relative volume 10.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	NUBI	-21.35%	2024-02-02 against the close of 2024-02-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	Honeycomb Battery Company and Nubia Brand International Corp. Announce Closing of Business Combination 02/02/2024 12:52 ET intraday	Day +1 no data Day +5 no data Best recovery within 5 no data Month-end is not shown: no closing price is available for 2024-02-29.
Close before and after $5.76 to $4.53 as traded Session open, high, low $5.30, $6.20, $4.25 Opening gap -7.99% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 78,275 shares, $354,586 Relative volume 2.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	DV	-21.28%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	DoubleVerify Reports Fourth Quarter and Full Year 2023 Financial Results 02/28/2024 16:05 ET after hours DoubleVerify to Participate in Investor Conferences on Tuesday, March 5th, Wednesday, March 6th and Thursday, March 7th 2024 02/29/2024	Day +1 -19.85% 2024-03-01 Day +5 -18.83% 2024-03-07 Best recovery within 5 -18.83% 2024-03-07 11.5% of the drop was recovered five sessions later. Month end -21.28% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $39.24 to $30.89 split-adjusted Session open, high, low $31.62, $34.20, $30.78 Opening gap -19.42% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 10,257,926 shares, $316,867,334 Relative volume 7.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	RYAM	-21.20%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	RYAM Announces Fourth Quarter and Full Year 2023 Results and Provides Improved Outlook for 2024 02/27/2024 16:35 ET after hours RYAM and VERSO ENERGY Execute Memorandum of Understanding to Explore eSAF 02/27/2024	Day +1 -21.89% 2024-02-29 Day +5 -13.82% 2024-03-06 Best recovery within 5 -9.91% 2024-03-04 34.8% of the drop was recovered five sessions later. Month end -21.89% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $4.34 to $3.42 split-adjusted Session open, high, low $3.36, $3.84, $3.15 Opening gap -22.58% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 1,758,062 shares, $6,012,572 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	BELFA Same release as rank 49	-21.19%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Bel Reports Fourth Quarter and Full Year 2023 Results 02/21/2024 17:20 ET after hours	Day +1 -20.54% 2024-02-23 Day +5 -20.52% 2024-02-29 Best recovery within 5 -20.02% 2024-02-26 3.2% of the drop was recovered five sessions later. Month end -20.52% on 2024-02-29
Close before and after $74.87 to $59.00 split-adjusted Session open, high, low $61.20, $61.20, $51.00 Opening gap -18.25% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 37,485 shares, $2,211,615 Relative volume 8.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	MIST	-21.13%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants 02/28/2024 16:37 ET after hours Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants 02/29/2024	Day +1 -24.41% 2024-03-01 Day +5 -29.58% 2024-03-07 Best recovery within 5 -24.41% 2024-03-01 Five sessions later the drop was 40.0% bigger, at -29.58%. Month end -21.13% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $2.13 to $1.68 split-adjusted Session open, high, low $1.63, $2.10, $1.61 Opening gap -23.47% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 3,200,423 shares, $5,376,711 Relative volume 26.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	BSGM	-21.03%	2024-02-06 against the close of 2024-02-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases 02/06/2024 08:30 ET premarket	Day +1 -28.14% 2024-02-07 Day +5 -29.55% 2024-02-13 Best recovery within 5 -17.30% 2024-02-09 Five sessions later the drop was 40.5% bigger, at -29.55%. Month end -36.97% on 2024-02-29
Close before and after $1.09 to $0.8594 as traded Session open, high, low $1.07, $1.15, $0.8402 Opening gap -1.68% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 310,733 shares, $267,044 Relative volume 10.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	NARI	-20.84%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Inari Medical Reports Fourth Quarter 2023 Financial Results 02/28/2024 16:05 ET after hours	Day +1 -22.07% 2024-03-01 Day +5 -27.43% 2024-03-07 Best recovery within 5 -22.07% 2024-03-01 Five sessions later the drop was 31.6% bigger, at -27.43%. Month end -20.84% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $58.26 to $46.12 as traded Session open, high, low $49.90, $51.00, $45.18 Opening gap -14.35% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 6,333,291 shares, $292,091,381 Relative volume 13.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	SNCR	-20.83%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Synchronoss to Unveil New Version of AI-Powered Personal Cloud Platform at Mobile World Congress 02/21/2024 08:00 ET premarket	Day +1 -24.67% 2024-02-22 Day +5 -21.08% 2024-02-28 Best recovery within 5 -12.99% 2024-02-23 Five sessions later the drop was 1.2% bigger, at -21.08%. Month end -23.77% on 2024-02-29
Close before and after $12.24 to $9.69 as traded Session open, high, low $12.41, $12.41, $7.40 Opening gap +1.39% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 841,644 shares, $8,155,530 Relative volume 12.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	NUS	-20.71%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Nu Skin Enterprises Reports Fourth Quarter and Full-year 2023 Results Above Company Guidance 02/14/2024 16:05 ET after hours	Day +1 -21.46% 2024-02-16 Day +5 -27.83% 2024-02-23 Best recovery within 5 -21.46% 2024-02-16 Five sessions later the drop was 34.4% bigger, at -27.83%. Month end -28.28% on 2024-02-29
Close before and after $17.43 to $13.82 split-adjusted Session open, high, low $13.37, $14.60, $13.37 Opening gap -23.29% Close inside the session range 0.37 of the range, where 1.00 is the high Session volume 2,956,595 shares, $40,860,143 Relative volume 5.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
96	KZIA	-20.61%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint 02/21/2024 07:30 ET premarket	Day +1 -24.54% 2024-02-22 Day +5 -34.49% 2024-02-28 Best recovery within 5 -22.40% 2024-02-23 Five sessions later the drop was 67.3% bigger, at -34.49%. Month end -35.73% on 2024-02-29
Close before and after $19.85 to $15.76 split-adjusted Session open, high, low $21.40, $22.49, $14.28 Opening gap +7.84% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 412,759 shares, $6,503,018 Relative volume 67.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
97	ATNI	-20.53%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	ATN Reports Fourth Quarter and Full Year 2023 Results; Provides 2024 Outlook 02/21/2024 16:45 ET after hours	Day +1 +2.95% 2024-02-23 Day +5 -5.92% 2024-02-29 Best recovery within 5 +2.95% 2024-02-23 71.2% of the drop was recovered five sessions later. Month end -5.92% on 2024-02-29
Close before and after $35.65 to $28.33 split-adjusted Session open, high, low $35.39, $35.39, $27.50 Opening gap -0.73% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 163,400 shares, $4,629,122 Relative volume 3.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	AMN	-20.53%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AMN Healthcare Announces Fourth Quarter and Full Year 2023 Results 02/15/2024 16:15 ET after hours	Day +1 -25.14% 2024-02-20 Day +5 -28.08% 2024-02-26 Best recovery within 5 -23.79% 2024-02-21 Five sessions later the drop was 36.8% bigger, at -28.08%. Month end -27.52% on 2024-02-29
Close before and after $77.63 to $61.69 split-adjusted Session open, high, low $67.05, $67.05, $61.18 Opening gap -13.63% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 3,297,239 shares, $203,406,674 Relative volume 7.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	OCGN	-20.28%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST 02/22/2024 16:05 ET after hours	Day +1 -9.69% 2024-02-26 Day +5 -3.67% 2024-03-01 Best recovery within 5 -0.66% 2024-02-27 81.9% of the drop was recovered five sessions later. Month end -6.08% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $0.9966 to $0.7945 split-adjusted Session open, high, low $0.9500, $0.9601, $0.7425 Opening gap -4.68% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 16,819,280 shares, $13,362,918 Relative volume 11.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	NGM	-20.16%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP 02/26/2024 09:03 ET premarket	Day +1 -14.66% 2024-02-27 Day +5 -20.42% 2024-03-04 Best recovery within 5 -14.66% 2024-02-27 Five sessions later the drop was 1.3% bigger, at -20.42%. Month end -20.42% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $1.91 to $1.53 as traded Session open, high, low $1.55, $1.61, $1.50 Opening gap -18.85% Close inside the session range 0.23 of the range, where 1.00 is the high Session volume 6,605,603 shares, $10,073,545 Relative volume 16.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 737 smaller events this month are held out of this month's eligible pool; switch to include them. 267 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

1 candidate event for this board could not be anchored to a trading session and is not listed.

1 event was left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

7 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In February 2024, the median decliner was 1.3% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 57 of the 100 events, at a median of -26.2%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Earnings	57	57.0%	-26.2%	-26.2%	98.2% of 57
Other Announcement	17	17.0%	-28.2%	-32.2%	94.1% of 17
Clinical Trial Results	8	8.0%	Fewer than 10 events in this group, so no figures are shown.
Offering / Dilution	8	8.0%	Fewer than 10 events in this group, so no figures are shown.
M&A / Acquisition	3	3.0%	Fewer than 10 events in this group, so no figures are shown.

4 other catalyst types, 7 events: Reverse Merger / Shell, Contract / Partnership, Uplisting / Compliance, FDA & Regulatory.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	99.0% of 99	0.0% recovered, of 99
Day +5	96.0% of 99	1.3% deeper below baseline, of 99
Month end	97.7% of 87	2.0% deeper below baseline, of 87
Month end falls before day +5 for 21 of these 87 events, so this row is not a later horizon than the one above it. 87 of the 100 events have a month-end close later than the measured session; 11 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside February 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
GBNH	2Offering / Dilution, Uplisting / Compliance	-46.69%
BKKT	2Offering / Dilution, Other Announcement	-43.14%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
ROI	2024-01, 2023-12, 2023-11	-35.93%
PHUN	2024-01, 2023-12	-61.29%
VRM	2024-01, 2023-11	-42.38%
CAMP	2024-01, 2023-12	-24.22%
ACRS	2024-01, 2023-11	-86.44%
EVA	2024-01, 2023-11	-77.86%
RGS	2024-01, 2023-12	-21.05%
MDRX	2024-01, 2023-12	-20.02%
POLthis month too	2023-12, 2023-11	-46.91%
FBIO	2023-12, 2023-11	-37.02%
ATRA	2023-12, 2023-11	-80.17%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

Industry

43 other industries, 47 events

Industry not known: 21.0%

1 event on this board carries the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against January 2024

100 events in the comparable window.

January 2024 median -18.7%, selected from the 8,201 events in that month's eligible pool

February 2024 median -28.3%, 9.6 points steeper than January 2024. February 2024's median is taken over the 100 ranked rows, selected from the 9,696 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.